Collegium Pharmaceutical: Q1 Earnings Snapshot
STOUGHTON, Mass. (AP) — STOUGHTON, Mass. (AP) — Collegium Pharmaceutical Inc. (COLL) on Thursday reported a loss of $17.4 million in its first quarter.
The Stoughton, Massachusetts-based company said it had a loss of 51 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.32 per share.
The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of $1.32 per share.
The specialty pharmaceutical company posted revenue of $144.8 million in the period, which topped Street forecasts. Four analysts surveyed by Zacks expected $139.1 million.
Collegium Pharmaceutical expects full-year revenue in the range of $565 million to $580 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL
